{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:55:03Z","timestamp":1778126103614,"version":"3.51.4"},"reference-count":122,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T00:00:00Z","timestamp":1525392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00705-018-3856-0","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T17:23:53Z","timestamp":1525454633000},"page":"2313-2325","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Nanoparticle vaccines against viral infections"],"prefix":"10.1007","volume":"163","author":[{"given":"Fernando B.","family":"Sulczewski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel B.","family":"Liszbinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro R. T.","family":"Rom\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5380-8930","authenticated-orcid":false,"given":"Luiz Carlos","family":"Rodrigues Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,4]]},"reference":[{"key":"3856_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s40121-013-0014-6","volume":"2","author":"G Lien","year":"2013","unstructured":"Lien G, Heymann DL (2013) The problems with polio: toward eradication. Infect Dis Ther 2:167\u2013174","journal-title":"Infect Dis Ther"},{"key":"3856_CR2","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/j.vaccine.2017.01.031","volume":"35","author":"F Chappuis","year":"2017","unstructured":"Chappuis F, Farinelli T, Deckx H et al (2017) Immunogenicity and estimation of antibody persistence following vaccination with an inactivated virosomal hepatitis A vaccine in adults: a 20-year follow-up study. Vaccine 35:1448\u20131454. https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.031","journal-title":"Vaccine"},{"key":"3856_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4033-2","author":"M Paz-Zulueta","year":"2018","unstructured":"Paz-Zulueta M, \u00c1lvarez-Paredes L, Rodr\u00edguez D\u00edaz JC et al (2018) Prevalence of high-risk HPV genotypes, categorised by their quadrivalent and nine-valent HPV vaccination coverage, and the genotype association with high-grade lesions. BMC Cancer. https:\/\/doi.org\/10.1186\/s12885-018-4033-2","journal-title":"BMC Cancer"},{"key":"3856_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.01.065","author":"P Pezzotti","year":"2018","unstructured":"Pezzotti P, Bellino S, Prestinaci F et al (2018) The impact of immunization programs on 10 vaccine preventable diseases in Italy: 1900\u20132015. Vaccine. https:\/\/doi.org\/10.1016\/j.vaccine.2018.01.065","journal-title":"Vaccine"},{"key":"3856_CR5","doi-asserted-by":"publisher","first-page":"20161903","DOI":"10.1098\/rspb.2016.1903","volume":"283","author":"SL Nuismer","year":"2016","unstructured":"Nuismer SL, Althouse BM, May R et al (2016) Eradicating infectious disease using weakly transmissible vaccines. Proc R Soc B Biol Sci 283:20161903. https:\/\/doi.org\/10.1098\/rspb.2016.1903","journal-title":"Proc R Soc B Biol Sci"},{"key":"3856_CR6","doi-asserted-by":"publisher","first-page":"5193","DOI":"10.1016\/j.vaccine.2016.05.063","volume":"34","author":"M Carole Tevi-Benissan","year":"2016","unstructured":"Carole Tevi-Benissan M, Moturi E, Anya BPM et al (2016) Contribution of polio eradication initiative to effective new vaccine introduction in Africa, 2010\u20132015. Vaccine 34:5193\u20135198. https:\/\/doi.org\/10.1016\/j.vaccine.2016.05.063","journal-title":"Vaccine"},{"key":"3856_CR7","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.nano.2015.11.005","volume":"12","author":"M Shaalan","year":"2016","unstructured":"Shaalan M, Saleh M, El-Mahdy M, El-Matbouli M (2016) Recent progress in applications of nanoparticles in fish medicine: a review. Nanomed Nanotechnol Biol Med 12:701\u2013710. https:\/\/doi.org\/10.1016\/j.nano.2015.11.005","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"3856_CR8","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s12038-009-0114-3","volume":"34","author":"TD Nandedkar","year":"2009","unstructured":"Nandedkar TD (2009) Nanovaccine : recent developments in vaccination. Proteins 34:995\u20131003. https:\/\/doi.org\/10.1007\/s12038-009-0114-3","journal-title":"Proteins"},{"key":"3856_CR9","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.addr.2007.05.017","volume":"60","author":"LJ Peek","year":"2008","unstructured":"Peek LJ, Middaugh CR, Berkland C (2008) Nanotechnology in vaccine delivery. Adv Drug Deliv Rev 60:915\u2013928. https:\/\/doi.org\/10.1016\/j.addr.2007.05.017","journal-title":"Adv Drug Deliv Rev"},{"key":"3856_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.vaccine.2013.11.069","volume":"32","author":"L Zhao","year":"2014","unstructured":"Zhao L, Seth A, Wibowo N et al (2014) Nanoparticle vaccines. Vaccine 32:327\u2013337. https:\/\/doi.org\/10.1016\/j.vaccine.2013.11.069","journal-title":"Vaccine"},{"key":"3856_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1477-3155-9-55","volume":"9","author":"A Mahapatro","year":"2011","unstructured":"Mahapatro A, Singh DK (2011) Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines. J Nanobiotechnol 9:55. https:\/\/doi.org\/10.1186\/1477-3155-9-55","journal-title":"J Nanobiotechnol"},{"key":"3856_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/08982100802354665","volume":"18","author":"H Barani","year":"2008","unstructured":"Barani H, Montazer M (2008) A review on applications of liposomes in textile processing. J Liposome Res 18:249\u2013262. https:\/\/doi.org\/10.1080\/08982100802354665","journal-title":"J Liposome Res"},{"key":"3856_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1063\/1.3276915","volume":"131","author":"CC Chiu","year":"2009","unstructured":"Chiu CC, Moore PB, Shinoda W, Nielsen SO (2009) Size-dependent hydrophobic to hydrophilic transition for nanoparticles: a molecular dynamics study. J Chem Phys 131:1\u20139. https:\/\/doi.org\/10.1063\/1.3276915","journal-title":"J Chem Phys"},{"key":"3856_CR14","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1084\/jem.20100223","volume":"207","author":"K Crozat","year":"2010","unstructured":"Crozat K, Guiton R, Contreras V et al (2010) The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8alpha+ dendritic cells. J Exp Med 207:1283\u20131292. https:\/\/doi.org\/10.1084\/jem.20100223","journal-title":"J Exp Med"},{"key":"3856_CR15","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1210\/en.2009-1082","volume":"151","author":"BS Zolnik","year":"2010","unstructured":"Zolnik BS, Gonz\u00e1lez-Fern\u00e1ndez \u00c1\u0301, Sadrieh N, Dobrovolskaia MA (2010) Minireview: nanoparticles and the immune system. Endocrinology 151:458\u2013465. https:\/\/doi.org\/10.1210\/en.2009-1082","journal-title":"Endocrinology"},{"key":"3856_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018319","author":"C Arama","year":"2011","unstructured":"Arama C, Giusti P, Bostr\u00f6m S et al (2011) Interethnic differences in antigen-presenting cell activation and TLR responses in malian children during Plasmodium falciparum malaria. PLoS One. https:\/\/doi.org\/10.1371\/journal.pone.0018319","journal-title":"PLoS One"},{"key":"3856_CR17","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3389\/fimmu.2014.00359","volume":"5","author":"AE Barry","year":"2014","unstructured":"Barry AE, Arnott A (2014) Strategies for designing and monitoring malaria vaccines targeting diverse antigens. Front Immunol 5:359. https:\/\/doi.org\/10.3389\/fimmu.2014.00359","journal-title":"Front Immunol"},{"key":"3856_CR18","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4161\/hv.26796","volume":"10","author":"A Bolhassani","year":"2014","unstructured":"Bolhassani A, Javanzad S, Saleh T et al (2014) Polymeric nanoparticles potent vectors for vaccine delivery targeting cancer and infectious diseases. Hum Vaccines Immunother 10:321\u2013323. https:\/\/doi.org\/10.4161\/hv.26796","journal-title":"Hum Vaccines Immunother"},{"key":"3856_CR19","first-page":"13","volume":"2","author":"T Mocan","year":"2014","unstructured":"Mocan T (2014) Nanoparticles-based cancer vaccines. Biotechnol Mol Biol Nanomed 2:13\u201314","journal-title":"Biotechnol Mol Biol Nanomed"},{"key":"3856_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ejpb.2011.10.016.Lipid","volume":"80","author":"S Wadhwa","year":"2013","unstructured":"Wadhwa S, Jain A, Woodward JG, Mumper RJ (2013) Lipid nanocapsule as vaccine carriers for his-tagged proteins: evaluation of antigen-specific immune responses to HIV I His-Gag p41 and systemic inflammatory responses. Eur J Pharm Biopharm 80:315\u2013322. https:\/\/doi.org\/10.1016\/j.ejpb.2011.10.016.Lipid","journal-title":"Eur J Pharm Biopharm"},{"key":"3856_CR21","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1021\/nn304235j","volume":"7","author":"M Zaric","year":"2013","unstructured":"Zaric M, Lyubomska O, Touzelet O et al (2013) Skin dendritic cell targeting via microneedle arrays laden with co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses. ACS Nano 7:2042\u20132055","journal-title":"ACS Nano"},{"key":"3856_CR22","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1586\/erv.11.17","volume":"10","author":"D Christensen","year":"2011","unstructured":"Christensen D, Korsholm KS, Andersen P, Agger EM (2011) Cationic liposomes as vaccine adjuvants. Expert Rev Vaccines 10:513\u2013521","journal-title":"Expert Rev Vaccines"},{"key":"3856_CR23","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1080\/21645515.2015.1117714","volume":"12","author":"AL Silva","year":"2016","unstructured":"Silva AL, Soema PC, Sl\u00fctter B et al (2016) PLGA particulate delivery systems for subunit vaccines: linking particle properties to immunogenicity. Hum Vaccines Immunother 12:1056\u20131069","journal-title":"Hum Vaccines Immunother"},{"key":"3856_CR24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nmat2960.Interbilayer-Crosslinked","volume":"10","author":"JJ Moon","year":"2011","unstructured":"Moon JJ, Suh H, Bershteyn A et al (2011) Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nat Mater 10:243\u2013251. https:\/\/doi.org\/10.1038\/nmat2960.Interbilayer-Crosslinked","journal-title":"Nat Mater"},{"key":"3856_CR25","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.biotechadv.2015.05.010","volume":"33","author":"AS Cordeiro","year":"2015","unstructured":"Cordeiro AS, Alonso MJ, de la Fuente M (2015) Nanoengineering of vaccines using natural polysaccharides. Biotechnol Adv 33:1279\u20131293","journal-title":"Biotechnol Adv"},{"key":"3856_CR26","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5501\/wjv.v4.i3.156","volume":"4","author":"M Trovato","year":"2015","unstructured":"Trovato M, De Berardinis P (2015) Novel antigen delivery systems. World J Virol 4:156\u2013168. https:\/\/doi.org\/10.5501\/wjv.v4.i3.156","journal-title":"World J Virol"},{"key":"3856_CR27","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1440-1711.2005.01319.x","volume":"83","author":"MT Sanders","year":"2005","unstructured":"Sanders MT, Brown LE, Deliyannis G, Pearse MJ (2005) ISCOMTM-based vaccines: the second decade. Immunol Cell Biol 83:119\u2013128","journal-title":"Immunol Cell Biol"},{"key":"3856_CR28","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.vaccine.2012.10.083","volume":"31","author":"N Kushnir","year":"2012","unstructured":"Kushnir N, Streatfield SJ, Yusibov V (2012) Virus-like particles as a highly efficient vaccine platform: diversity of targets and production systems and advances in clinical development. Vaccine 31:58\u201383. https:\/\/doi.org\/10.1016\/j.vaccine.2012.10.083","journal-title":"Vaccine"},{"key":"3856_CR29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s12275-017-7058-3","volume":"55","author":"H Jeong","year":"2017","unstructured":"Jeong H, Seong BL (2017) Exploiting virus-like particles as innovative vaccines against emerging viral infections. J Microbiol 55:220\u2013230. https:\/\/doi.org\/10.1007\/s12275-017-7058-3","journal-title":"J Microbiol"},{"key":"3856_CR30","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.tibtech.2013.09.002","volume":"31","author":"Q Zhao","year":"2013","unstructured":"Zhao Q, Li S, Yu H et al (2013) Virus-like particle-based human vaccines: quality assessment based on structural and functional properties. Trends Biotechnol 31:654\u2013663. https:\/\/doi.org\/10.1016\/j.tibtech.2013.09.002","journal-title":"Trends Biotechnol"},{"key":"3856_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s11671-016-1554-y","author":"Y Wang","year":"2016","unstructured":"Wang Y, Wang Y, Kang N et al (2016) Construction and immunological evaluation of CpG-Au @ HBc virus-like nanoparticles as a potential vaccine. Nanoscale Res Lett. https:\/\/doi.org\/10.1186\/s11671-016-1554-y","journal-title":"Nanoscale Res Lett"},{"key":"3856_CR32","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1002\/jps.20696","volume":"95","author":"H Mach","year":"2006","unstructured":"Mach H, Volkin DB, Troutman RD et al (2006) Disassembly and reassembly of yeast-derived recombinant human papillomavirus virus-like particles (HPV VLPs). J Pharm Sci 95:2195\u20132206. https:\/\/doi.org\/10.1002\/jps.20696","journal-title":"J Pharm Sci"},{"key":"3856_CR33","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00705-016-2812-0","volume":"161","author":"B Binjawadagi","year":"2016","unstructured":"Binjawadagi B, Lakshmanappa YS, Longchao Z et al (2016) Development of a porcine reproductive and respiratory syndrome virus-like-particle-based vaccine and evaluation of its immunogenicity in pigs. Arch Virol 161:1579\u20131589. https:\/\/doi.org\/10.1007\/s00705-016-2812-0","journal-title":"Arch Virol"},{"key":"3856_CR34","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jconrel.2016.12.039","volume":"247","author":"S Dhakal","year":"2017","unstructured":"Dhakal S, Hiremath J, Bondra K et al (2017) Biodegradable nanoparticle delivery of inactivated swine influenza virus vaccine provides heterologous cell-mediated immune response in pigs. J Control Release 247:194\u2013205. https:\/\/doi.org\/10.1016\/j.jconrel.2016.12.039","journal-title":"J Control Release"},{"key":"3856_CR35","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.micpath.2016.05.012","volume":"97","author":"M Amirnasr","year":"2016","unstructured":"Amirnasr M, Fallah tafti T, Sankian M et al (2016) Immunization against HTLV-I with chitosan and tri-methylchitosan nanoparticles loaded with recombinant env23 and env13 antigens of envelope protein gp46. Microb Pathog 97:38\u201344. https:\/\/doi.org\/10.1016\/j.micpath.2016.05.012","journal-title":"Microb Pathog"},{"key":"3856_CR36","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.biomaterials.2017.03.034","volume":"130","author":"SY Kim","year":"2017","unstructured":"Kim SY, Noh YW, Kang TH et al (2017) Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity. Biomaterials 130:56\u201366. https:\/\/doi.org\/10.1016\/j.biomaterials.2017.03.034","journal-title":"Biomaterials"},{"key":"3856_CR37","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/vaccines4040034","volume":"4","author":"A Gutjahr","year":"2016","unstructured":"Gutjahr A, Phelip C, Coolen A-L et al (2016) Biodegradable polymeric nanoparticles-based vaccine adjuvants for lymph nodes targeting. Vaccines 4:34. https:\/\/doi.org\/10.3390\/vaccines4040034","journal-title":"Vaccines"},{"key":"3856_CR38","doi-asserted-by":"publisher","first-page":"6401","DOI":"10.1021\/acsnano.5b02014","volume":"9","author":"J Xiang","year":"2015","unstructured":"Xiang J, Xu L, Gong H et al (2015) Antigen-loaded upconversion nanoparticles for dendritic cell stimulation, tracking, and vaccination in dendritic cell-based immunotherapy. ACS Nano 9:6401\u20136411. https:\/\/doi.org\/10.1021\/acsnano.5b02014","journal-title":"ACS Nano"},{"key":"3856_CR39","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jconrel.2006.01.006","volume":"112","author":"ST Reddy","year":"2006","unstructured":"Reddy ST, Rehor A, Schmoekel HG et al (2006) In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Control Release 112:26\u201334. https:\/\/doi.org\/10.1016\/j.jconrel.2006.01.006","journal-title":"J Control Release"},{"key":"3856_CR40","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/nbt1332","volume":"25","author":"ST Reddy","year":"2007","unstructured":"Reddy ST, Van Der Vlies J, Simeoni E et al (2007) Exploiting lymphatic transport and complement activation in nanoparticle vaccines. Nat Biotechnol 25:1159\u20131164. https:\/\/doi.org\/10.1038\/nbt1332","journal-title":"Nat Biotechnol"},{"key":"3856_CR41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol 11:373\u2013384. https:\/\/doi.org\/10.1038\/ni.1863","journal-title":"Nat Immunol"},{"key":"3856_CR42","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1152\/advan.00058.2013","volume":"37","author":"R Suresh","year":"2013","unstructured":"Suresh R, Mosser DM (2013) Pattern recognition receptors in innate immunity, host defense, and immunopathology. Adv Physiol Educ 37:284\u2013291. https:\/\/doi.org\/10.1152\/advan.00058.2013","journal-title":"Adv Physiol Educ"},{"key":"3856_CR43","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.it.2016.10.008","volume":"38","author":"C Chiang","year":"2017","unstructured":"Chiang C, Gack MU (2017) Post-translational control of intracellular pathogen sensing pathways. Trends Immunol 38:39\u201352. https:\/\/doi.org\/10.1016\/j.it.2016.10.008","journal-title":"Trends Immunol"},{"key":"3856_CR44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1089\/jir.2016.0095","volume":"37","author":"H Kato","year":"2017","unstructured":"Kato H, Oh S-W, Fujita T (2017) RIG-I-like receptors and type I interferonopathies. J Interf Cytokine Res 37:207\u2013213. https:\/\/doi.org\/10.1089\/jir.2016.0095","journal-title":"J Interf Cytokine Res"},{"key":"3856_CR45","doi-asserted-by":"publisher","first-page":"30","DOI":"10.4110\/in.2013.13.1.30","volume":"13","author":"Y Lee","year":"2013","unstructured":"Lee Y, Lee Y, Kim K et al (2013) Induction of potent antigen-specific cytotoxic T cell response by PLGA-nanoparticles containing antigen and TLR agonist. Immune Netw 13:30\u201333","journal-title":"Immune Netw"},{"key":"3856_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3006516.Generation","author":"AV Li","year":"2013","unstructured":"Li AV, Moon JJ, Abraham W et al (2013) Generation of effector memory T cell-based mucosal and systemic immunity with pulmonary nanoparticle vaccination adrienne. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.3006516.Generation","journal-title":"Sci Transl Med"},{"key":"3856_CR47","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jconrel.2017.02.031","volume":"251","author":"MO Mohsen","year":"2017","unstructured":"Mohsen MO, Gomes AC, Cabral-Miranda G et al (2017) Delivering adjuvants and antigens in separate nanoparticles eliminates the need of physical linkage for effective vaccination. J Control Release 251:92\u2013100. https:\/\/doi.org\/10.1016\/j.jconrel.2017.02.031","journal-title":"J Control Release"},{"key":"3856_CR48","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1002\/hep.26654","volume":"59","author":"S Lv","year":"2014","unstructured":"Lv S, Wang J, Dou S et al (2014) Nanoparticles encapsulating hepatitis B virus cytosine\u2013phosphate\u2013guanosine induce therapeutic immunity against HBV infection. Hepatology 59:385\u2013394. https:\/\/doi.org\/10.1002\/hep.26654","journal-title":"Hepatology"},{"key":"3856_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01077","author":"M Ebrahimian","year":"2017","unstructured":"Ebrahimian M, Hashemi M, Maleki M et al (2017) Co-delivery of dual toll-like receptor agonists and antigen in poly(lactic-co-glycolic) acid\/polyethylenimine cationic hybrid nanoparticles promote efficient in vivo immune responses. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2017.01077","journal-title":"Front Immunol"},{"key":"3856_CR50","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.celrep.2016.12.073","volume":"18","author":"JA Leleux","year":"2017","unstructured":"Leleux JA, Pradhan P, Roy K (2017) Biophysical attributes of CpG presentation control TLR9 signaling to differentially polarize systemic immune responses. Cell Rep 18:700\u2013710. https:\/\/doi.org\/10.1016\/j.celrep.2016.12.073","journal-title":"Cell Rep"},{"key":"3856_CR51","doi-asserted-by":"publisher","first-page":"6249","DOI":"10.4049\/jimmunol.1001093","volume":"187","author":"Y Mukai","year":"2011","unstructured":"Mukai Y, Yoshinaga T, Yoshikawa M et al (2011) Induction of endoplasmic reticulum-endosome fusion for antigen cross-presentation induced by poly (-glutamic acid) nanoparticles. J Immunol 187:6249\u20136255. https:\/\/doi.org\/10.4049\/jimmunol.1001093","journal-title":"J Immunol"},{"key":"3856_CR52","doi-asserted-by":"publisher","first-page":"9743","DOI":"10.1021\/nn403085w","volume":"7","author":"NM Molino","year":"2013","unstructured":"Molino NM, Anderson AKL, Nelson EL, Wang SW (2013) Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation. ACS Nano 7:9743\u20139752. https:\/\/doi.org\/10.1021\/nn403085w","journal-title":"ACS Nano"},{"key":"3856_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006684","author":"LH Turner","year":"2017","unstructured":"Turner LH, Kinder JM, Wilburn A et al (2017) Preconceptual Zika virus asymptomatic infection protects against secondary prenatal infection. PLoS Pathog. https:\/\/doi.org\/10.1371\/journal.ppat.1006684","journal-title":"PLoS Pathog"},{"key":"3856_CR54","doi-asserted-by":"publisher","first-page":"6302","DOI":"10.1016\/j.vaccine.2017.09.076","volume":"35","author":"C Pileggi","year":"2017","unstructured":"Pileggi C, Papadopoli R, Bianco A, Pavia M (2017) Hepatitis B vaccine and the need for a booster dose after primary vaccination. Vaccine 35:6302\u20136307. https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.076","journal-title":"Vaccine"},{"key":"3856_CR55","doi-asserted-by":"publisher","first-page":"6202","DOI":"10.1016\/j.vaccine.2017.09.036","volume":"35","author":"S Ng","year":"2017","unstructured":"Ng S, Saborio S, Kuan G et al (2017) Association between haemagglutination inhibiting antibodies and protection against clade 6B viruses in 2013 and 2015. Vaccine 35:6202\u20136207. https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.036","journal-title":"Vaccine"},{"key":"3856_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1128\/CVI.00557-12","volume":"20","author":"BA Reikie","year":"2013","unstructured":"Reikie BA, Naidoo S, Ruck CE et al (2013) Antibody responses to vaccination among South African HIV-exposed and unexposed uninfected infants during the first 2\u00a0years of life. Clin Vaccine Immunol 20:33\u201338. https:\/\/doi.org\/10.1128\/CVI.00557-12","journal-title":"Clin Vaccine Immunol"},{"key":"3856_CR57","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1038\/nri2868","volume":"10","author":"MF Bachmann","year":"2010","unstructured":"Bachmann MF, Jennings GT (2010) Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol 10:787\u2013796","journal-title":"Nat Rev Immunol"},{"key":"3856_CR58","first-page":"5","volume-title":"Early BCR events and antigen capture, processing, and loading on MHC class II on B cells","author":"AM Avalos","year":"2014","unstructured":"Avalos AM, Ploegh HL (2014) Early BCR events and antigen capture, processing, and loading on MHC class II on B cells. Front, Immunol, p 5"},{"key":"3856_CR59","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1073\/pnas.1112648109","volume":"109","author":"JJ Moon","year":"2012","unstructured":"Moon JJ, Suh H, Li AV et al (2012) Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction. Proc Natl Acad Sci 109:1080\u20131085. https:\/\/doi.org\/10.1073\/pnas.1112648109","journal-title":"Proc Natl Acad Sci"},{"key":"3856_CR60","doi-asserted-by":"publisher","first-page":"17247","DOI":"10.1073\/pnas.1305000110","volume":"110","author":"R Agarwal","year":"2013","unstructured":"Agarwal R, Singh V, Jurney P et al (2013) Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms. Proc Natl Acad Sci 110:17247\u201317252. https:\/\/doi.org\/10.1073\/pnas.1305000110","journal-title":"Proc Natl Acad Sci"},{"key":"3856_CR61","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1002\/smll.201100001","volume":"7","author":"F Zhao","year":"2011","unstructured":"Zhao F, Zhao Y, Liu Y et al (2011) Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small 7:1322\u20131337","journal-title":"Small"},{"key":"3856_CR62","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1083\/jcb.128.6.1111","volume":"128","author":"C Rosette","year":"1995","unstructured":"Rosette C, Karin M (1995) Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-\u03baB. J Cell Biol 128:1111\u20131119. https:\/\/doi.org\/10.1083\/jcb.128.6.1111","journal-title":"J Cell Biol"},{"key":"3856_CR63","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12985-016-0506-6","volume":"13","author":"J Jans","year":"2016","unstructured":"Jans J, elMoussaoui H, de Groot R et al (2016) Actin- and clathrin-dependent mechanisms regulate interferon gamma release after stimulation of human immune cells with respiratory syncytial virus. Virol J 13:52. https:\/\/doi.org\/10.1186\/s12985-016-0506-6","journal-title":"Virol J"},{"key":"3856_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0140824","volume":"10","author":"LE Piccini","year":"2015","unstructured":"Piccini LE, Castilla V, Damonte EB (2015) Dengue-3 virus entry into vero cells: role of clathrin-mediated endocytosis in the outcome of infection. PLoS One 10:1\u201317. https:\/\/doi.org\/10.1371\/journal.pone.0140824","journal-title":"PLoS One"},{"key":"3856_CR65","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1093\/femsre\/fuu004","volume":"39","author":"C Cruz-Oliveira","year":"2015","unstructured":"Cruz-Oliveira C, Freire JM, Concei\u00e7\u00e3o TM et al (2015) Receptors and routes of dengue virus entry into the host cells. FEMS Microbiol Rev 39:155\u2013170. https:\/\/doi.org\/10.1093\/femsre\/fuu004","journal-title":"FEMS Microbiol Rev"},{"key":"3856_CR66","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1128\/JVI.03620-14","volume":"89","author":"I Benedicto","year":"2015","unstructured":"Benedicto I, Gondar V, Molina-Jim\u00e9nez F et al (2015) Clathrin mediates infectious hepatitis C virus particle egress. J Virol 89:4180\u20134190. https:\/\/doi.org\/10.1128\/JVI.03620-14","journal-title":"J Virol"},{"key":"3856_CR67","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1128\/cvi.00170-15","volume":"22","author":"B Wu","year":"2015","unstructured":"Wu B, Geng S, Bi Y et al (2015) Herpes simplex virus 1 suppresses the function of lung dendritic cells via caveolin-1. Clin Vaccine Immunol 22:883\u2013895. https:\/\/doi.org\/10.1128\/cvi.00170-15","journal-title":"Clin Vaccine Immunol"},{"key":"3856_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1556-276X-9-1","volume":"9","author":"Y Hu","year":"2014","unstructured":"Hu Y, Ehrich M, Fuhrman K, Zhang C (2014) In vitro performance of lipid-PLGA hybrid nanoparticles as an antigen delivery system: lipid composition matters. Nanoscale Res Lett 9:1\u201310","journal-title":"Nanoscale Res Lett"},{"key":"3856_CR69","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.ijpharm.2013.06.013","volume":"454","author":"M Weyland","year":"2013","unstructured":"Weyland M, Griveau A, Bejaud J et al (2013) Lipid nanocapsule functionalization by lipopeptides derived from human papillomavirus type-16 capsid for nucleic acid delivery into cancer cells. Int J Pharm 454:756\u2013764. https:\/\/doi.org\/10.1016\/j.ijpharm.2013.06.013","journal-title":"Int J Pharm"},{"key":"3856_CR70","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s11051-015-3029-y","volume":"17","author":"AP Walczak","year":"2015","unstructured":"Walczak AP, Hendriksen PJM, Woutersen RA et al (2015) Bioavailability and biodistribution of differently charged polystyrene nanoparticles upon oral exposure in rats. J Nanopart Res 17:231. https:\/\/doi.org\/10.1007\/s11051-015-3029-y","journal-title":"J Nanopart Res"},{"key":"3856_CR71","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2165\/00137696-200503030-00001","volume":"3","author":"A Bernkop-Schn\u00fcrch","year":"2005","unstructured":"Bernkop-Schn\u00fcrch A, Greimel A (2005) Thiomers: the next generation of mucoadhesive polymers. Am J Drug Deliv 3:141\u2013154. https:\/\/doi.org\/10.2165\/00137696-200503030-00001","journal-title":"Am J Drug Deliv"},{"key":"3856_CR72","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1586\/14760584.2015.1064772","volume":"14","author":"JA Salazar-Gonz\u00e1lez","year":"2015","unstructured":"Salazar-Gonz\u00e1lez JA, Gonz\u00e1lez-Ortega O, Rosales-Mendoza S (2015) Gold nanoparticles and vaccine development. Expert Rev Vaccines 14:1197\u20131211. https:\/\/doi.org\/10.1586\/14760584.2015.1064772","journal-title":"Expert Rev Vaccines"},{"key":"3856_CR73","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ijpharm.2016.10.065","volume":"515","author":"M Ebrahimian","year":"2016","unstructured":"Ebrahimian M, Hashemi M, Maleki M et al (2016) Induction of a balanced Th1\/Th2 immune responses by co-delivery of PLGA\/ovalbumin nanospheres and CpG ODNs\/PEI-SWCNT nanoparticles as TLR9 agonist in BALB\/c mice. Int J Pharm 515:708\u2013720. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.10.065","journal-title":"Int J Pharm"},{"key":"3856_CR74","doi-asserted-by":"publisher","first-page":"6617","DOI":"10.1039\/c4nr01202j","volume":"6","author":"D Mahony","year":"2014","unstructured":"Mahony D, Cavallaro AS, Mody KT et al (2014) In vivo delivery of bovine viral diahorrea virus, E2 protein using hollow mesoporous silica nanoparticles. Nanoscale 6:6617. https:\/\/doi.org\/10.1039\/c4nr01202j","journal-title":"Nanoscale"},{"key":"3856_CR75","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1177\/0394632016656192","volume":"29","author":"T Toda","year":"2016","unstructured":"Toda T, Yoshino S (2016) Enhancement of ovalbumin-specific Th1, Th2, and Th17 immune responses by amorphous silica nanoparticles. Int J Immunopathol Pharmacol 29:408\u2013420. https:\/\/doi.org\/10.1177\/0394632016656192","journal-title":"Int J Immunopathol Pharmacol"},{"key":"3856_CR76","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jcis.2013.03.005","volume":"400","author":"T Liu","year":"2013","unstructured":"Liu T, Liu H, Fu C et al (2013) Silica nanorattle with enhanced protein loading: a potential vaccine adjuvant. J Colloid Interface Sci 400:168\u2013174. https:\/\/doi.org\/10.1016\/j.jcis.2013.03.005","journal-title":"J Colloid Interface Sci"},{"key":"3856_CR77","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nri1372","volume":"4","author":"S-Y Seong","year":"2004","unstructured":"Seong S-Y, Matzinger P (2004) Opinion: hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol 4:469\u2013478. https:\/\/doi.org\/10.1038\/nri1372","journal-title":"Nat Rev Immunol"},{"key":"3856_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1021\/ja2108905","volume":"134","author":"DF Moyano","year":"2012","unstructured":"Moyano DF, Goldsmith M, Solfiell DJ et al (2012) Nanoparticle hydrophobicity dictates immune response. J Am Chem Soc 134:1\u20137","journal-title":"J Am Chem Soc"},{"key":"3856_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0005071","volume":"10","author":"SW Metz","year":"2016","unstructured":"Metz SW, Tian S, Hoekstra G et al (2016) Precisely molded nanoparticle displaying DENV-E proteins induces robust serotype-specific neutralizing antibody responses. PLoS Negl Trop Dis 10:1\u201317. https:\/\/doi.org\/10.1371\/journal.pntd.0005071","journal-title":"PLoS Negl Trop Dis"},{"key":"3856_CR80","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1016\/j.vaccine.2015.02.016","volume":"33","author":"T Hunsawong","year":"2015","unstructured":"Hunsawong T, Sunintaboon P, Warit S et al (2015) A novel dengue virus serotype-2 nanovaccine induces robust humoral and cell-mediated immunity in mice. Vaccine 33:1702\u20131710. https:\/\/doi.org\/10.1016\/j.vaccine.2015.02.016","journal-title":"Vaccine"},{"key":"3856_CR81","doi-asserted-by":"publisher","first-page":"e0003958","DOI":"10.1371\/journal.pntd.0003958","volume":"9","author":"T Hunsawong","year":"2015","unstructured":"Hunsawong T, Sunintaboon P, Warit S et al (2015) Immunogenic properties of a BCG adjuvanted chitosan nanoparticle-based dengue vaccine in human dendritic cells. PLoS Negl Trop Dis 9:e0003958. https:\/\/doi.org\/10.1371\/journal.pntd.0003958","journal-title":"PLoS Negl Trop Dis"},{"key":"3856_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-016-0598-z","author":"N Nantachit","year":"2016","unstructured":"Nantachit N, Sunintaboon P, Ubol S (2016) Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination. Virol J. https:\/\/doi.org\/10.1186\/s12985-016-0598-z","journal-title":"Virol J"},{"key":"3856_CR83","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1186\/1750-9378-2-15.Voir","volume":"27","author":"World Health Organization (WHO)","year":"2017","unstructured":"World Health Organization (WHO) (2017) Hepatitis B vaccines: WHO position paper\u2014July 2017. Wkly Epidemiol Rec 27:369\u2013392. https:\/\/doi.org\/10.1186\/1750-9378-2-15.Voir","journal-title":"Wkly Epidemiol Rec"},{"issue":"6","key":"3856_CR84","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","volume":"142","author":"HB El-Serag","year":"2012","unstructured":"El-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142(6):1264\u20131273. https:\/\/doi.org\/10.1053\/j.gastro.2011.12.061","journal-title":"Gastroenterology"},{"key":"3856_CR85","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s12026-013-8403-1","volume":"56","author":"CA Shaw","year":"2013","unstructured":"Shaw CA, Tomljenovic L (2013) Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity. Immunol Res 56:304\u2013316. https:\/\/doi.org\/10.1007\/s12026-013-8403-1","journal-title":"Immunol Res"},{"key":"3856_CR86","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1177\/0961203311430221","volume":"21","author":"L Tomljenovic","year":"2012","unstructured":"Tomljenovic L, Shaw CA (2012) Mechanisms of aluminum adjuvant toxicity and autoimmunity in pediatric populations. Lupus 21:223\u2013230","journal-title":"Lupus"},{"key":"3856_CR87","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2012.00406","author":"H HogenEsch","year":"2012","unstructured":"HogenEsch H (2012) Mechanism of immunopotentiation and safety of aluminum adjuvants. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2012.00406","journal-title":"Front Immunol"},{"key":"3856_CR88","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.nano.2008.05.006","volume":"4","author":"DJ Bharali","year":"2008","unstructured":"Bharali DJ, Pradhan V, Elkin G et al (2008) Novel nanoparticles for the delivery of recombinant hepatitis B vaccine. Nanomed Nanotechnol Biol Med 4:311\u2013317. https:\/\/doi.org\/10.1016\/j.nano.2008.05.006","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"3856_CR89","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.vaccine.2013.10.074","volume":"32","author":"F Chiara","year":"2013","unstructured":"Chiara F, Bartolucci GB, Cattai M et al (2013) Hepatitis B vaccination of adolescents: significance of non-protective antibodies. Vaccine 32:62\u201368. https:\/\/doi.org\/10.1016\/j.vaccine.2013.10.074","journal-title":"Vaccine"},{"key":"3856_CR90","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.intimp.2016.08.007","volume":"39","author":"KK Sahu","year":"2016","unstructured":"Sahu KK, Pandey RS (2016) Immunological evaluation of colonic delivered Hepatitis B surface antigen loaded TLR-4 agonist modified solid fat nanoparticles. Int Immunopharmacol 39:343\u2013352. https:\/\/doi.org\/10.1016\/j.intimp.2016.08.007","journal-title":"Int Immunopharmacol"},{"key":"3856_CR91","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1016\/j.vaccine.2016.04.084","volume":"34","author":"AK Dinda","year":"2016","unstructured":"Dinda AK, Bhat M, Srivastava S et al (2016) Novel nanocarrier for oral hepatitis B vaccine. Vaccine 34:3076\u20133081. https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.084","journal-title":"Vaccine"},{"key":"3856_CR92","doi-asserted-by":"publisher","DOI":"10.2217\/nnm-2017-0138","author":"S Jesus","year":"2017","unstructured":"Jesus S, Soares E, Borchard G, Borges O (2017) Poly-\u03f5-caprolactone\/chitosan nanoparticles provide strong adjuvant effect for hepatitis B antigen. Nanomedicine. https:\/\/doi.org\/10.2217\/nnm-2017-0138","journal-title":"Nanomedicine"},{"key":"3856_CR93","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/j.nano.2016.07.010","volume":"12","author":"A Pietrzak-Nguyen","year":"2016","unstructured":"Pietrzak-Nguyen A, Piradashvili K, Fichter M et al (2016) MPLA-coated hepatitis B virus surface antigen (HBsAg) nanocapsules induce vigorous T cell responses in cord blood derived human T cells. Nanomed Nanotechnol Biol Med 12:2383\u20132394. https:\/\/doi.org\/10.1016\/j.nano.2016.07.010","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"3856_CR94","first-page":"14","volume-title":"Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies","author":"Y Ahmed","year":"2017","unstructured":"Ahmed Y, Tian M, Gao Y (2017) Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies. AIDS Res, Ther, p 14"},{"key":"3856_CR95","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal1321","author":"B Julg","year":"2017","unstructured":"Julg B, Tartaglia LJ, Keele BF et al (2017) Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aal1321","journal-title":"Sci Transl Med"},{"key":"3856_CR96","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/imr.12516","volume":"275","author":"B Korber","year":"2017","unstructured":"Korber B, Hraber P, Wagh K, Hahn BH (2017) Polyvalent vaccine approaches to combat HIV-1 diversity. Immunol Rev 275:230\u2013244","journal-title":"Immunol Rev"},{"key":"3856_CR97","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1056\/NEJMp1613362","volume":"375","author":"M Caskey","year":"2016","unstructured":"Caskey M, Klein F, Nussenzweig MC (2016) Broadly neutralizing antibodies for HIV-1 prevention or immunotherapy. N Engl J Med 375:2019\u20132021. https:\/\/doi.org\/10.1056\/NEJMp1613362","journal-title":"N Engl J Med"},{"key":"3856_CR98","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac4223","author":"RW Sanders","year":"2015","unstructured":"Sanders RW, Van Gils MJ, Derking R et al (2015) HIV-1 neutralizing antibodies induced by native-like envelope trimers. Science. https:\/\/doi.org\/10.1126\/science.aac4223","journal-title":"Science"},{"key":"3856_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-015-0210-4","author":"K Sliepen","year":"2015","unstructured":"Sliepen K, Ozorowski G, Burger JA et al (2015) Presenting native-like HIV -1 envelope trimers on ferritin nanoparticles improves their immunogenicity. Retrovirology. https:\/\/doi.org\/10.1186\/s12977-015-0210-4","journal-title":"Retrovirology"},{"key":"3856_CR100","doi-asserted-by":"publisher","first-page":"12041","DOI":"10.1038\/ncomms12041","volume":"7","author":"L He","year":"2016","unstructured":"He L, de Val N, Morris CD et al (2016) Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles. Nat Commun 7:12041. https:\/\/doi.org\/10.1038\/ncomms12041","journal-title":"Nat Commun"},{"key":"3856_CR101","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.vaccine.2016.12.049","volume":"35","author":"MG Brewer","year":"2017","unstructured":"Brewer MG, DiPiazza A, Acklin J et al (2017) Nanoparticles decorated with viral antigens are more immunogenic at low surface density. Vaccine 35:774\u2013781. https:\/\/doi.org\/10.1016\/j.vaccine.2016.12.049","journal-title":"Vaccine"},{"key":"3856_CR102","doi-asserted-by":"publisher","first-page":"e00443-17","DOI":"10.1128\/JVI.00443-17","volume":"91","author":"S Bale","year":"2017","unstructured":"Bale S, Goebrecht G, Stano A et al (2017) Covalent linkage of HIV-1 trimers to synthetic liposomes elicits improved B cell and antibody responses. J Virol 91:e00443-17. https:\/\/doi.org\/10.1128\/JVI.00443-17","journal-title":"J Virol"},{"key":"3856_CR103","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.imlet.2017.05.002","volume":"187","author":"H Rostami","year":"2017","unstructured":"Rostami H, Ebtekar M, Shafiee MAMHY, Mahdavi M (2017) Co-utilization of a TLR5 agonist and nano-formulation of HIV-1 vaccine candidate leads to increased vaccine immunogenicity and decreased immunogenic dose: a preliminary studypt. Immunol Lett 187:19\u201326. https:\/\/doi.org\/10.1016\/j.imlet.2017.05.002","journal-title":"Immunol Lett"},{"key":"3856_CR104","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1021\/bc5002246","volume":"25","author":"S Pejawar-gaddy","year":"2015","unstructured":"Pejawar-gaddy S, Kovacs JM, Barouch DH et al (2015) Design of lipid nanocapsule delivery vehicles for multivalent display of recombinant Env trimers in HIV vaccination. Bioconjug Chem 25:1470\u20131478","journal-title":"Bioconjug Chem"},{"key":"3856_CR105","first-page":"673","volume":"12","author":"ME Aikins","year":"2017","unstructured":"Aikins ME, Bazzill J, Moon J (2017) Vaccine nanoparticles for protection against HIV infection. Future Med 12:673\u2013682","journal-title":"Future Med"},{"key":"3856_CR106","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/S0264-410X(02)00481-4","volume":"21","author":"M Muszkat","year":"2003","unstructured":"Muszkat M, Greenbaum E, Ben-Yehuda A et al (2003) Local and systemic immune response in nursing-home elderly following intranasal or intramuscular immunization with inactivated influenza vaccine. Vaccine 21:1180\u20131186. https:\/\/doi.org\/10.1016\/S0264-410X(02)00481-4","journal-title":"Vaccine"},{"key":"3856_CR107","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1080\/21645515.2015.1114195","volume":"12","author":"F Su","year":"2016","unstructured":"Su F, Patel GB, Hu S, Chen W (2016) Induction of mucosal immunity through systemic immunization: Phantom or reality? Hum Vaccines Immunother 12:1070\u20131079","journal-title":"Hum Vaccines Immunother"},{"key":"3856_CR108","doi-asserted-by":"publisher","DOI":"10.1186\/1477-3155-12-19","author":"G Rioux","year":"2014","unstructured":"Rioux G, Mathieu C, Russell A et al (2014) PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine. J Nanobiotechnol. https:\/\/doi.org\/10.1186\/1477-3155-12-19","journal-title":"J Nanobiotechnol"},{"key":"3856_CR109","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijpharm.2014.08.032","volume":"475","author":"S Dehghan","year":"2014","unstructured":"Dehghan S, Tafaghodi M, Bolourieh T et al (2014) Rabbit nasal immunization against influenza by dry-powder form of chitosan nanospheres encapsulated with influenza whole virus and adjuvants. Int J Pharm 475:1\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2014.08.032","journal-title":"Int J Pharm"},{"issue":"10","key":"3856_CR110","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2147\/IJN.S72264","volume":"30","author":"KA Ross","year":"2015","unstructured":"Ross KA, Wu W, Huntimer L et al (2015) Hemagglutinin-based polyanhydride nanovaccines against H5N1 influenza elicit protective virus neutralizing titers and cell-mediated immunity. Int J Nanomed 30(10):229\u2013243. https:\/\/doi.org\/10.2147\/IJN.S72264","journal-title":"Int J Nanomed"},{"key":"3856_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2017.01.019","author":"S Dhakal","year":"2017","unstructured":"Dhakal S, Goodman J, Bondra K et al (2017) Polyanhydride nanovaccine against swine influenza virus in pigs. Vaccine. https:\/\/doi.org\/10.1016\/j.vaccine.2017.01.019","journal-title":"Vaccine"},{"key":"3856_CR112","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-016-0321-6","author":"CJ Hu","year":"2017","unstructured":"Hu CJ, Chien C, Liu M et al (2017) Multi-antigen avian influenza a (H7N9) virus-like particles: particulate characterizations and immunogenicity evaluation in murine and avian models. BMC Biotechnol. https:\/\/doi.org\/10.1186\/s12896-016-0321-6","journal-title":"BMC Biotechnol"},{"key":"3856_CR113","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1089\/vim.2015.0144","volume":"29","author":"SM Singh","year":"2016","unstructured":"Singh SM, Alkie TN, Abdelaziz KT et al (2016) Characterization of immune responses to an inactivated avian influenza virus vaccine adjuvanted with nanoparticles containing CpG ODN. Viral Immunol 29:269\u2013275. https:\/\/doi.org\/10.1089\/vim.2015.0144","journal-title":"Viral Immunol"},{"key":"3856_CR114","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.nano.2016.08.030","volume":"13","author":"CP Karch","year":"2017","unstructured":"Karch CP, Li J, Kulangara C et al (2017) Vaccination with self-adjuvanted protein nanoparticles provides protection against lethal influenza challenge. Nanomed Nanotechnol Biol Med 13:241\u2013251. https:\/\/doi.org\/10.1016\/j.nano.2016.08.030","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"3856_CR115","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1016\/j.bmc.2012.04.031","volume":"20","author":"M Somiya","year":"2012","unstructured":"Somiya M, Yoshimoto N, Iijima M et al (2012) Targeting of polyplex to human hepatic cells by bio-nanocapsules, hepatitis B virus surface antigen L protein particles. Bioorg Med Chem 20:3873\u20133879. https:\/\/doi.org\/10.1016\/j.bmc.2012.04.031","journal-title":"Bioorg Med Chem"},{"key":"3856_CR116","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/nmat2960.Interbilayer-Crosslinked","volume":"10","author":"JJ Moon","year":"2011","unstructured":"Moon JJ, Suh H, Bershteyn A et al (2011) Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses. Nat Mater 10:243\u2013251. https:\/\/doi.org\/10.1038\/nmat2960.Interbilayer-Crosslinked","journal-title":"Nat Mater"},{"key":"3856_CR117","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijpharm.2016.03.013","volume":"504","author":"S Jesus","year":"2016","unstructured":"Jesus S, Soares E, Costa J et al (2016) Immune response elicited by an intranasally delivered HBsAg low-dose adsorbed to poly-\u03b5-caprolactone based nanoparticles. Int J Pharm 504:59\u201369. https:\/\/doi.org\/10.1016\/j.ijpharm.2016.03.013","journal-title":"Int J Pharm"},{"key":"3856_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/10717544.2015.1038856","volume":"1","author":"M Zhao","year":"2015","unstructured":"Zhao M, Li M, Zhang Z et al (2015) Induction of HIV-1 gag specific immune responses by cationic micelles mediated delivery of gag mRNA. Drug Deliv 1:1\u201312","journal-title":"Drug Deliv"},{"key":"3856_CR119","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26654","author":"S Lv","year":"2013","unstructured":"Lv S, Wang J, Dou S et al (2013) Nanoparticles encapsulating HBV-CpG induce therapeutic immunity against hepatitis B virus infection. Hepatology. https:\/\/doi.org\/10.1002\/hep.26654","journal-title":"Hepatology"},{"key":"3856_CR120","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0005071","volume":"10","author":"SW Metz","year":"2016","unstructured":"Metz SW, Tian S, Hoekstra G et al (2016) Precisely molded nanoparticle displaying DENV-E proteins induces robust serotype-specific neutralizing antibody responses. PLoS Negl Trop Dis 10:1\u201317. https:\/\/doi.org\/10.1371\/journal.pntd.0005071","journal-title":"PLoS Negl Trop Dis"},{"key":"3856_CR121","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01223","author":"T Ebensen","year":"2017","unstructured":"Ebensen T, Debarry J, Pedersen GK et al (2017) Mucosal administration of cycle-di-nucleotide-adjuvanted virosomes efficiently induces protection against influenza H5N1 in mice. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2017.01223","journal-title":"Front Immunol"},{"key":"3856_CR122","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1007\/s00705-017-3560-5","volume":"162","author":"AS Turmagambetova","year":"2017","unstructured":"Turmagambetova AS, Alexyuk PG, Bogoyavlenskiy AP et al (2017) Adjuvant activity of saponins from Kazakhstani plants on the immune responses to subunit influenza vaccine. Arch Virol 162:3817\u20133826. https:\/\/doi.org\/10.1007\/s00705-017-3560-5","journal-title":"Arch Virol"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-018-3856-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-018-3856-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-018-3856-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:17:29Z","timestamp":1744175849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-018-3856-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,4]]},"references-count":122,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["3856"],"URL":"https:\/\/doi.org\/10.1007\/s00705-018-3856-0","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,4]]},"assertion":[{"value":"24 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}